![Christopher Cain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Cain
Direktor/Vorstandsmitglied bei
COGENT BIOSCIENCES, INC.
Vermögen: - $ am 31.05.2026
Profil
Dr. Christopher Cain is an Independent Director at Damora Therapeutics, Inc., an Independent Director at Jade Biosciences, Inc., an Independent Director at Viridian Therapeutics, Inc. and an Independent Director at Cogent Biosciences, Inc. He is on the Board of Directors at Damora Therapeutics, Inc., Jade Biosciences, Inc., Viridian Therapeutics, Inc., Jade Biosciences, Inc. (United States) and Cogent Biosciences, Inc. Dr. Cain was previously employed as a Vice President by Samsara BioCapital LP and a Senior Associate by Apple Tree Venture Management Llc//vc.
He received his undergraduate degree from the University of California, Santa Barbara and a doctorate degree from The University of California, San Francisco.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
| 01.07.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Christopher Cain
| Unternehmen | Position | Beginn |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 06.07.2020 |
| VIRIDIAN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.03.2025 |
| JADE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 28.04.2025 |
| DAMORA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.11.2025 |
Ehemalige bekannte Positionen von Christopher Cain
| Unternehmen | Position | Ende |
|---|---|---|
Samsara BioCapital LP
 Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01.02.2020 |
Apple Tree Venture Management Llc//vc
 Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Private-Equity-Analyst | 28.02.2019 |
Ausbildung von Christopher Cain
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Samsara BioCapital LP
Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Wählen Sie MarketScreener 
